We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a ...

The most significant driver of the stock’s surge in 2025 has been the U.S. Food and Drug Administration approval and ...

India's first dengue vaccine, expected to launch in 2026 after local trials; WHO-approved jab offers two-dose protection ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

The diabetes drug metformin provided overweight/obese patients with osteoarthritis (OA) of the knee with significantly ...

The country needs to develop a new strategy as both punitive tariffs from and genial relations with giants leave it ...

DelveInsight's " Aplastic Anemia Market Insights, Epidemiology, and Market Forecast- 2034" report delivers an in-depth ...

Gurgaon: The Muslim community took to the streets in the city and neighbouring towns after Friday prayers — wearing black ...

The on-again, off-again Tesla Cybertruck launch in Australia appears to at last be approaching on again, with a version of the electrified horror show doing the rounds at our EV conferences, and the b ...

New research identifies 17 modifiable factors that can reduce your risk of stroke, dementia, and depression simultaneously, ...

Daiichi Sankyo seeks Japanese approval for Enhertu to treat patients with HER2 positive metastatic solid tumours: Tokyo Friday, April 25, 2025, 09:00 Hrs [IST] Daiichi Sankyo has ...